Forte Biosciences Inc. (FBRX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Forte Biosciences Inc. (FBRX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

16.49

1.87 (12.79%)

At close: Jan 15, 2025, 11:40 AM

undefined% (undefined)

Bid	16.2
Market Cap	105.43M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-16.38
PE Ratio (ttm)	-1.01
Forward PE	n/a
Analyst	Buy

Ask	16.49
Volume	22,577
Avg. Volume (20D)	571,560
Open	15.70
Previous Close	14.62
Day's Range	15.01 - 17.64
52-Week Range	4.11 - 28.68
Beta	undefined

About FBRX

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas....

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Apr 13, 2017

Employees 11

Stock Exchange NASDAQ

Ticker Symbol FBRX

Website https://www.fortebiorx.com

Analyst Forecast

According to 3 analyst ratings, the average rating for FBRX stock is "Buy." The 12-month stock price forecast is $68.75, which is an increase of 316.92% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

1 month ago · Source

-18.1%

Forte Biosciences shares are trading lower after t... Unlock content with Pro Subscription

5 months ago · Source

-20.51%

Forte Biosciences shares are trading lower after the company reported worse-than-expected Q2 EPS results.

News

1 week ago · zacks.com

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why

Forte Biosciences (FBRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro...

1 month ago · zacks.com

Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going

1 month ago · businesswire.com

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced ...

1 month ago · zacks.com

Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?

Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).